Cargando…

The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research

The objective of this study is to assess whether statin use is associated with beneficial effects on COPD outcomes. We conducted a systematic review and meta-analysis of all available studies describing the association between statin use and COPD mortality, exacerbations and cardiovascular events. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Chao, Wu, Yinfang, Xu, Zhiwei, Lv, Dan, Zhang, Chao, Lai, Tianwen, Li, Wen, Shen, Huahao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639730/ https://www.ncbi.nlm.nih.gov/pubmed/26553965 http://dx.doi.org/10.1038/srep16461

Ejemplares similares

YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling
por: Lai, Tianwen, et al.
Publicado: (2016)

Lipid metabolism in chronic obstructive pulmonary disease
por: Chen, Haipin, et al.
Publicado: (2019)

Genetic Polymorphism of Matrix Metalloproteinase Family and Chronic Obstructive Pulmonary Disease Susceptibility: a Meta-analysis
por: Zhou, Hongbin, et al.
Publicado: (2013)

TNF-α-308G/A Polymorphism Contributes to Obstructive Sleep Apnea Syndrome Risk: Evidence Based on 10 Case-Control Studies
por: Wu, Yanping, et al.
Publicado: (2014)

No Independent Influence of Statins on the Chronic Obstructive Pulmonary Disease Exacerbation Rate: A Cohort Observation Study Over 10 Years
por: Yayan, Josef, et al.
Publicado: (2021)

Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis
por: Lai, Tianwen, et al.
Publicado: (2015)

Corrigendum: Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis
por: Lai, Tianwen, et al.
Publicado: (2015)

The Influence of Prior Statin Use on the Prevalence and Exacerbation of Chronic Obstructive Pulmonary Disease in an Adult Population
por: Kim, Joo-Hee, et al.
Publicado: (2022)

Smoking-promoted oxidative DNA damage response is highly correlated to lung carcinogenesis
por: Cao, Chao, et al.
Publicado: (2016)

Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies
por: Horita, Nobuyuki, et al.
Publicado: (2014)

Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies
por: Li, Wen-Feng, et al.
Publicado: (2017)

Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink
por: Smith, Margaret C, et al.
Publicado: (2021)

Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids
por: Huang, Yi-Jen, et al.
Publicado: (2021)

Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study
por: Damkjær, Mathias, et al.
Publicado: (2021)

Vascular Endothelial Growth Factor Genotypes and Haplotypes Contribute to the Susceptibility of Obstructive Sleep Apnea Syndrome
por: Cao, Chao, et al.
Publicado: (2014)

Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease
por: Santibáñez, Miguel, et al.
Publicado: (2016)

Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study [Corrigendum]
Publicado: (2021)

Impact of statins and ACE inhibitors on mortality after COPD exacerbations
por: Mortensen, Eric M, et al.
Publicado: (2009)

Pulmonary Embolism in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Cao, Yao-Qian, et al.
Publicado: (2018)

Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis
por: Wang, Xiaohui, et al.
Publicado: (2017)

IL-17-Mediated Inflammation Promotes Cigarette Smoke-Induced Genomic Instability
por: Cao, Chao, et al.
Publicado: (2021)

Hematological Parameters for Predicting Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Karkra, Rohan, et al.
Publicado: (2023)

Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review
por: Qian, Yang, et al.
Publicado: (2023)

Efficiency and Safety of Pulmonary Rehabilitation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: He, Mei, et al.
Publicado: (2015)

Exacerbations of Chronic Obstructive Pulmonary Disease
por: Garvey, Christine, et al.
Publicado: (2012)

The Chronic Obstructive Pulmonary Disease Exacerbation
por: Sherk, Peter A., et al.
Publicado: (2000)

Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhou, Xianghui, et al.
Publicado: (2015)

Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis
por: Cao, Chao, et al.
Publicado: (2012)

Ozone-induced IL-17A and neutrophilic airway inflammation is orchestrated by the caspase-1-IL-1 cascade
por: Che, Luanqing, et al.
Publicado: (2016)

Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
por: Suissa, Samy, et al.
Publicado: (2012)

Novel biomarkers for prediction of mortality after acute exacerbation of chronic obstructive pulmonary disease
por: Michalopoulou, H, et al.
Publicado: (2013)

Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality
por: Casas-Mendez, Fernando, et al.
Publicado: (2018)

Better with Time: Reductions in Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Blagev, Denitza P.
Publicado: (2020)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2018)

Acute exacerbation of chronic obstructive pulmonary disease treated by extracorporeal carbon dioxide removal
por: Li, Min, et al.
Publicado: (2019)

Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Segal, Leopoldo N., et al.
Publicado: (2015)

Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Publicado: (2007)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Acute Exacerbations
por: Wedzicha, J.A., et al.
Publicado: (2006)

Management of Exacerbations in Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qe42euld21qn4mdn0hktcjti6o